Stock Research: DiaSorin

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

DiaSorin

BIT:DIA IT0003492391
70
  • Value
    44
  • Growth
    61
  • Safety
    Safety
    66
  • Combined
    77
  • Sentiment
    69
  • 360° View
    360° View
    70
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

DiaSorin SpA develops, produces, and commercializes reagent kits for in vitro diagnostics. The company operates in the healthcare industry, specializing in infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring, and autoimmunity. The company operates in the Immunodiagnostics and Molecular Diagnostics markets. In the last fiscal year, the company had a market cap of $5,841 million, profits of $809 million, revenue of $1,227 million, and 3271 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 70 (better than 70% compared with alternatives), overall professional sentiment and financial characteristics for the stock DiaSorin are above average. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for DiaSorin. The consolidated Value Rank has an attractive rank of 66, which means that the share price of DiaSorin is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 66% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 61, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 69. But the company’s financing is risky with a Safety rank of 44. This means 56% of comparable companies have a safer financing structure than DiaSorin. ...read more

more
Index
MIB
Customer Focus EU
SDG 2
SDG 3
SDG 6
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
66 32 23 34
Growth
61 88 21 7
Safety
Safety
44 48 50 98
Sentiment
69 60 10 90
360° View
360° View
70 80 6 74
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
31 13 13 19
Opinions Change
50 50 10 64
Pro Holdings
n/a 73 31 90
Market Pulse
56 75 65 89
Sentiment
69 60 10 90
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
66 32 23 34
Growth
61 88 21 7
Safety Safety
44 48 50 98
Combined
77 75 6 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
54 34 33 31
Price vs. Earnings (P/E)
36 26 27 27
Price vs. Book (P/B)
64 40 37 37
Dividend Yield
52 47 39 37
Value
66 32 23 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
57 73 12 12
Profit Growth
74 83 12 54
Capital Growth
71 76 100 27
Stock Returns
25 56 18 32
Growth
61 88 21 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 20 22 92
Refinancing
21 53 59 71
Liquidity
54 61 53 92
Safety Safety
44 48 50 98

Similar Stocks

Discover high‑ranked alternatives to DiaSorin and broaden your portfolio horizons.

Azimut

BIT:AZM
Country: Italy
Industry: Asset Management & Custody
Size: Medium
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

SSE

LSE:SSE
Country: United Kingdom
Industry: Electric Utilities
Size: X-Large
Full Stock Analysis

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.